Vanderbilt-Ingram Cancer Center
-
March 11, 2022
New Clinician Spotlight: Jeffrey Tosoian
Jeffrey Tosoian, MD, MPH, joined the Department of Urology at Vanderbilt University Medical Center recently after completing his fellowship at the University of Michigan. -
March 10, 2022
Bots boost liver cancer outcome
Vanderbilt researchers report that robotic-assisted surgery is comparable, if not superior, to laparoscopic surgery for early-stage liver cancer patients. -
March 9, 2022
Research Staff Awards honor those who help drive science forward
Laboratory and administrative personnel at Vanderbilt University Medical Center were honored March 4 for research excellence during the 18th annual Research Staff Awards Ceremony. -
March 9, 2022
Martin shares colorectal cancer story, urges early detection
Vanderbilt Wilson County Hospital's Lori Martin uses her own experiences to educate patients about the importance of early detection of colorectal cancer. -
March 7, 2022
Study finds World Trade Center responders at higher risk for blood cancer-associated mutations
A study by Vanderbilt and New York City researchers found that 9/11 first responders to the World Trade Center have increased levels of mutations that escalate their risk for blood cancers or cardiovascular disease -
February 24, 2022
Melanoma treatment response
Targeting the interaction between melanoma and immune cells could improve responses to targeted cancer therapies, Vanderbilt researchers found. -
February 17, 2022
Park named director of Vanderbilt-Ingram Cancer Center
Ben Ho Park, MD, PhD, deputy director of the Vanderbilt-Ingram Cancer Center, has been named the center’s new director.